TDAG8 (GPR65) Inhibits Intestinal Inflammation in the DSS-Induced Experimental Colitis Mouse Model
Edward J Sanderlin, Swati Satturwar, Heng Hong, Kvin Lertpiriyapong, Mona Marie, Li V YangiD
Abstract
T cell death-associated gene 8 (TDAG8, also known as GPR65) is a proton-sensing G protein-coupled receptor (GPCR) predominantly expressed in immune cells. Genome-wide association studies identify TDAG8 as a susceptibility candidate gene linked to several human inflammatory diseases including inflammatory bowel disease (IBD), asthma, spondyloarthritis, and multiple sclerosis. In this study, our results demonstrate that mice deficient of TDAG8 exhibited more severe inflammatory phenotypes than wild-type mice in a chronic dextran sulfate sodium (DSS)-induced colitis mouse model. Several disease parameters, such as diarrhea, colon shortening, fibrosis, histopathological score, and mesenteric lymph node enlargement were aggravated in TDAG8-null mice in comparison to wild-type mice treated with DSS. Increased leukocyte infiltration and myofibroblast expansion were observed in colonic tissues of DSS-treated TDAG8-null mice. These changes may represent a cellular basis of the observed exacerbation of intestinal inflammation and fibrosis in these mice. In line with high expression of TDAG8 in infiltrated leukocytes, real-time RT-PCR revealed that TDAG8 mRNA expression was increased in inflamed intestinal tissue samples of IBD patients when compared to normal intestinal tissues. Altogether, our data demonstrate that TDAG8 suppresses intestinal inflammation and fibrosis in the chronic DSS-induced colitis mouse model, suggesting potentiation of TDAG8 with agonists may have anti-inflammatory therapeutic effects in IBD.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- GPR4 Deficiency Alleviates Intestinal Inflammation in a Mouse Model of Inflammatory Bowel Disease
Edward J Sanderlin, Nancy R Leffler, … Li V Yang·bioRxiv·Jun 14, 2016
- Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model
E. J. Sanderlin, M. Marie, … L. V. Yang·bioRxiv·Jan 29, 2019
- Systemic TLR7 agonism moderates disease severity in acute DSS-induced colitis in mice
Daniel Kazimierczyk, Brian Seed, Nitya Jain·bioRxiv·Nov 10, 2026
- Differential expression of soluble receptor for advanced glycation end-products (sRAGE) in mice susceptible or resistant to chronic colitis
M. Bramhall, K. Rich, … S. M. Cruickshank·bioRxiv·Aug 5, 2019
- GPR4 knockout attenuates intestinal inflammation and forestalls the development of colitis-associated colorectal cancer in murine models
M. A. Marie, E. J. Sanderlin, … L. V. Yang·bioRxiv·Mar 13, 2023
- Central Glucagon-Like Peptide-1 Agonism Ameliorates Colonic Inflammation in a Murine Model of Inflammatory Bowel Disease
Biren Desai, Kendra L. Francis, … Jarrad M. Scarlett·bioRxiv·Oct 24, 2026